Starling Oncology TOI
TOI
$6.20 +0.01 (+0.16%)
At close: Aug 11, 2026 · 4:00 PM EDT

Oncology Institute, Inc. (TOI) Long-Term Deferred Tax (2019 - 2020)

Oncology Institute's (TOI) quarterly Long-Term Deferred Tax came in at $70000.0 in Q3 2020, up 79.49% on a QoQ basis from $39000.0 in Q2 2020.

Oncology Institute, Inc. (TOI) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends

Oncology Institute (TOI) has 2 years of Long-Term Deferred Tax data on file, last reported at $70000.0 in Q3 2020.

  • Quarterly Long-Term Deferred Tax changed N/A year-over-year to $70000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $70000.0 (changed N/A YoY) and the FY2019 annual result came in at $25000.0, changed N/A from the prior year.
  • Long-Term Deferred Tax advanced to $70000.0 in Q3 2020, from $39000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $70000.0 in Q3 2020 to a low of $25000.0 in Q4 2019.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2020 70,000.00
Jun 30, 2020 39,000.00
Dec 31, 2019 25,000.00